Summary

Revenue : 000,000 M USD
Finance : 000,000 M USD
Earning Cap : 000,000 M USD
Invest : 000,000 M USD
R & D : 0000 People
Growth : 00% AGR

DIGDAL CAP

Overview

General Introduction Meikang Biotechnology Co., Ltd. is a national high-tech enterprise specializing in the research and development, production, sales, and service of medical diagnostic products. The company was founded in 2003 and stands on the coast of the East China Sea - Ningbo. In 2015, it was successfully listed on the Shenzhen Stock Exchange's ChiNext board. The main industries of Meikang Biotechnology are in vitro diagnostic reagents, instruments, and independent third-party medical diagnostic services. At present, 402 in vitro diagnostic reagent product registration certificates and 53 diagnostic instrument product registration certificates have been obtained. The product line covers biochemistry, luminescence, blood cells, urine, mass spectrometry, molecular diagnosis, blood lipid sub component detection VAP and POCT, etc. It is one of the few suppliers in China's lVD industry that can provide diagnostic reagents and diagnostic instruments simultaneously. Meikang Biotechnology adheres to the strategy of "in vitro diagnostic instruments as the engine, in vitro diagnostic products as the core, and in vitro diagnostic products+diagnostic services for common development", continuously improving the innovation ability and diagnostic service level of the three major professional technologies of product raw materials, reagents, and instruments, in order to enhance the company's comprehensive competitiveness.
Headquarter Ningbo
Establish Date 7/22/2003
Listed Code 300439.SZ
Listed Date 4/22/2015
Chairman Zou Bingde.
CEO Zou Jihua.
Website www.nbmksw.com

Buy Premium Now

$15/month billed now

View the full stack of insights immediately

Or 7 Days Free Charge for Trial

See feature available in the Trial and Premium

See our Solution and Servicetrial.solutionservice.trial

See our Uniquness and Value deliveringtrial.solutionservice.trial